Results from TCGA samples revealed that the expression of PPARG was augmented in patients with early stage bladder cancer and was attenuated in those with more advanced bladder cancer, which is in line with the result from prognosis nomogram chart. The gene discussed is PPARG; the disease is urinary bladder carcinoma.